Biology (May 2020)

Clinical Genetics of Prolidase Deficiency: An Updated Review

  • Marta Spodenkiewicz,
  • Michel Spodenkiewicz,
  • Maureen Cleary,
  • Marie Massier,
  • Giorgos Fitsialos,
  • Vincent Cottin,
  • Guillaume Jouret,
  • Céline Poirsier,
  • Martine Doco-Fenzy,
  • Anne-Sophie Lèbre

DOI
https://doi.org/10.3390/biology9050108
Journal volume & issue
Vol. 9, no. 5
p. 108

Abstract

Read online

Prolidase is a ubiquitous enzyme that plays a major role in the metabolism of proline-rich proteins. Prolidase deficiency is a rare autosomal recessive inborn metabolic and multisystemic disease, characterized by a protean association of symptoms, namely intellectual disability, recurrent infections, splenomegaly, skin lesions, auto-immune disorders and cytopenia. To our knowledge, no published review has assembled the different clinical data and research studies over prolidase deficiency. The aim of this study is to summarize the actual state of the art from the descriptions of all the patients with a molecular diagnosis of prolidase deficiency reported to date regarding the clinical, biological, histopathological features, therapeutic options and functional studies.

Keywords